As people fall asleep, their brainwave patterns change in a predictable, gradual way — measured by a mathematical method called DFA — with the same pattern seen in both healthy people and those with narcolepsy, indicating a shared biological process for falling asleep.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review could determine whether the 0.7 to 1.1 DFA exponent trajectory during sleep onset is reproducible across diverse populations, EEG montages, and analysis protocols, establishing it as a robust biomarker of sleep onset.
A systematic review and meta-analysis of all studies using DFA to quantify EEG scaling exponents during sleep onset, including only those with standardized MSLT protocols, 10+ participants per group, and reporting exponent values at wake, transition, and sleep onset. Studies must control for epoch length, filtering, and artifact rejection.
An RCT could test whether pharmacological agents that alter arousal (e.g., modafinil, caffeine) disrupt or preserve the 0.7→1.1 DFA trajectory, testing whether this pattern is a direct consequence of neural arousal systems.
A double-blind, crossover RCT of 30 healthy adults, randomized to receive modafinil (200 mg), caffeine (200 mg), or placebo before MSLT, with DFA scaling exponents measured every 5 seconds during sleep onset to assess whether the 0.7→1.1 trajectory is altered by arousal modulation.
A longitudinal cohort could determine whether the DFA exponent trajectory during sleep onset remains stable over time in healthy individuals and whether deviations predict future sleep disorders.
A prospective cohort study following 100 healthy adults aged 20–40, measuring DFA scaling exponents during MSLT annually for 5 years, with polysomnography and clinical sleep assessments to track development of insomnia, hypersomnia, or narcolepsy.
A case-control study could compare the DFA exponent trajectory in narcolepsy, idiopathic hypersomnia, and insomnia to determine if the 0.7→1.1 pattern is disrupted in other sleep disorders.
A matched case-control study comparing 40 narcolepsy patients, 40 idiopathic hypersomnia patients, and 40 insomnia patients with 40 healthy controls, all undergoing standardized MSLT with DFA analysis, measuring the slope and inflection point of the exponent trajectory.
A cross-sectional study could validate the 0.7→1.1 trajectory as a normative pattern across age groups and ethnicities using DFA.
A cross-sectional study of 300 healthy individuals stratified by age (20–30, 31–45, 46–60, 61–75), measuring DFA scaling exponents during MSLT to determine if the 0.7→1.1 trajectory is consistent across age groups.